181 related articles for article (PubMed ID: 26510915)
1. CAGE profiling of ncRNAs in hepatocellular carcinoma reveals widespread activation of retroviral LTR promoters in virus-induced tumors.
Hashimoto K; Suzuki AM; Dos Santos A; Desterke C; Collino A; Ghisletti S; Braun E; Bonetti A; Fort A; Qin XY; Radaelli E; Kaczkowski B; Forrest AR; Kojima S; Samuel D; Natoli G; Buendia MA; Faivre J; Carninci P
Genome Res; 2015 Dec; 25(12):1812-24. PubMed ID: 26510915
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of liver carcinogenesis in the mdr2-knockout mice.
Katzenellenbogen M; Mizrahi L; Pappo O; Klopstock N; Olam D; Jacob-Hirsch J; Amariglio N; Rechavi G; Domany E; Galun E; Goldenberg D
Mol Cancer Res; 2007 Nov; 5(11):1159-70. PubMed ID: 18025261
[TBL] [Abstract][Full Text] [Related]
3. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA.
Panzitt K; Tschernatsch MM; Guelly C; Moustafa T; Stradner M; Strohmaier HM; Buck CR; Denk H; Schroeder R; Trauner M; Zatloukal K
Gastroenterology; 2007 Jan; 132(1):330-42. PubMed ID: 17241883
[TBL] [Abstract][Full Text] [Related]
4. Deep sequencing of small RNA transcriptome reveals novel non-coding RNAs in hepatocellular carcinoma.
Law PT; Qin H; Ching AK; Lai KP; Co NN; He M; Lung RW; Chan AW; Chan TF; Wong N
J Hepatol; 2013 Jun; 58(6):1165-73. PubMed ID: 23376363
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide DNA methylome analysis reveals epigenetically dysregulated non-coding RNAs in human breast cancer.
Li Y; Zhang Y; Li S; Lu J; Chen J; Wang Y; Li Y; Xu J; Li X
Sci Rep; 2015 Mar; 5():8790. PubMed ID: 25739977
[TBL] [Abstract][Full Text] [Related]
6. [CLINICAL SIGNIFICANCE OF NONCODING RNA IN HEPATOCELLULAR CARCINOMA].
Eguchi H; Doki Y; Mori M
Nihon Geka Gakkai Zasshi; 2015 Nov; 116(6):366-9. PubMed ID: 26845888
[TBL] [Abstract][Full Text] [Related]
7. Retroviral vector sequences may interact with some internal promoters and influence expression.
Wu X; Holschen J; Kennedy SC; Ponder KP
Hum Gene Ther; 1996 Jan; 7(2):159-71. PubMed ID: 8788167
[TBL] [Abstract][Full Text] [Related]
8. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
[TBL] [Abstract][Full Text] [Related]
9. A biphasic response pattern of lipid metabolomics in the stage progression of hepatitis B virus X tumorigenesis.
Teng CF; Hsieh WC; Yang CW; Su HM; Tsai TF; Sung WC; Huang W; Su IJ
Mol Carcinog; 2016 Jan; 55(1):105-14. PubMed ID: 25594851
[TBL] [Abstract][Full Text] [Related]
10. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract][Full Text] [Related]
11. Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells.
Takayama K; Tsutsumi S; Katayama S; Okayama T; Horie-Inoue K; Ikeda K; Urano T; Kawazu C; Hasegawa A; Ikeo K; Gojyobori T; Ouchi Y; Hayashizaki Y; Aburatani H; Inoue S
Oncogene; 2011 Feb; 30(5):619-30. PubMed ID: 20890304
[TBL] [Abstract][Full Text] [Related]
12. Microarray profiling shows distinct differences between primary tumors and commonly used preclinical models in hepatocellular carcinoma.
Wang W; Iyer NG; Tay HT; Wu Y; Lim TK; Zheng L; Song IC; Kwoh CK; Huynh H; Tan PO; Chow PK
BMC Cancer; 2015 Oct; 15():828. PubMed ID: 26520397
[TBL] [Abstract][Full Text] [Related]
13. Role of non-coding RNAs in liver disease progression to hepatocellular carcinoma.
Heo MJ; Yun J; Kim SG
Arch Pharm Res; 2019 Jan; 42(1):48-62. PubMed ID: 30610616
[TBL] [Abstract][Full Text] [Related]
14. Specific genomic and transcriptomic aberrations in tumors induced by partial hepatectomy of a chronically inflamed murine liver.
Ella E; Heim D; Stoyanov E; Harari-Steinfeld R; Steinfeld I; Pappo O; Perlman TS; Nachmansson N; Rivkin L; Olam D; Abramovitch R; Wege H; Galun E; Goldenberg D
Oncotarget; 2014 Nov; 5(21):10318-31. PubMed ID: 25401338
[TBL] [Abstract][Full Text] [Related]
15. MYC-regulated genes involved in liver cell dysplasia identified in a transgenic model of liver cancer.
Hunecke D; Spanel R; Länger F; Nam SW; Borlak J
J Pathol; 2012 Dec; 228(4):520-33. PubMed ID: 22653869
[TBL] [Abstract][Full Text] [Related]
16. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
[TBL] [Abstract][Full Text] [Related]
17. Zinc finger transcription factor 191, directly binding to β-catenin promoter, promotes cell proliferation of hepatocellular carcinoma.
Liu G; Jiang S; Wang C; Jiang W; Liu Z; Liu C; Saiyin H; Yang X; Shen S; Jiang D; Zhou P; Han D; Hu X; Yi Q; Yu L
Hepatology; 2012 Jun; 55(6):1830-9. PubMed ID: 22213192
[TBL] [Abstract][Full Text] [Related]
18. Deep Cap Analysis of Gene Expression (CAGE): Genome-Wide Identification of Promoters, Quantification of Their Activity, and Transcriptional Network Inference.
Fort A; Fish RJ
Methods Mol Biol; 2017; 1543():111-126. PubMed ID: 28349423
[TBL] [Abstract][Full Text] [Related]
19. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
[TBL] [Abstract][Full Text] [Related]
20. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas.
Kim MY; Park E; Park JH; Park DH; Moon WS; Cho BH; Shin HS; Kim DG
Oncogene; 2001 Jul; 20(33):4568-75. PubMed ID: 11494152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]